Tr1x
Developer of a regulatory T cell-based therapy platform designed to treat autoimmune and inflammatory diseases by restoring immune tolerance. The company offers genetically engineered, stable, inflamm...
Valuation
$0
Share Price
N/A
Total Raised
$125M
Last Round
N/A